Rankings
▼
Calendar
LGVN Q1 2023 Earnings — Longeveron Inc. Revenue & Financial Results | Market Cap Arena
LGVN
Longeveron Inc.
$20M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$238,000
-35.7% YoY
Gross Profit
$35,000
14.7% margin
Operating Income
-$5M
-1981.5% margin
Net Income
-$5M
-1952.5% margin
EPS (Diluted)
$-2.21
QoQ Revenue Growth
+96.7%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$421,000
Balance Sheet
Total Assets
$22M
Total Liabilities
$5M
Stockholders' Equity
$16M
Cash & Equivalents
$5M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$238,000
$370,000
-35.7%
Gross Profit
$35,000
$165,000
-78.8%
Operating Income
-$5M
-$3M
-39.0%
Net Income
-$5M
-$4M
-32.4%
← FY 2023
All Quarters
Q2 2023 →